224 related articles for article (PubMed ID: 11520767)
1. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
McKelvie PA; Daniell M
Br J Ophthalmol; 2001 Sep; 85(9):1115-9. PubMed ID: 11520767
[TBL] [Abstract][Full Text] [Related]
2. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
[TBL] [Abstract][Full Text] [Related]
4. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Tunc M; Erbilen E
Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
[TBL] [Abstract][Full Text] [Related]
5. Ocular Surface Squamous Neoplasia.
Vazirani J; Mohapatra S
JAMA Ophthalmol; 2016 Feb; 134(2):e153666. PubMed ID: 26869128
[No Abstract] [Full Text] [Related]
6. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia.
Dogru M; Erturk H; Shimazaki J; Tsubota K; Gul M
Cornea; 2003 Oct; 22(7):627-39. PubMed ID: 14508259
[TBL] [Abstract][Full Text] [Related]
7. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
8. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Wilson MW; Hungerford JL; George SM; Madreperla SA
Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
[TBL] [Abstract][Full Text] [Related]
9. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
Khong JJ; Muecke J
Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
11. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Singh M; Gautam N; Kaur M
Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
Chen C; Louis D; Dodd T; Muecke J
Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
[TBL] [Abstract][Full Text] [Related]
14. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
Haas K; Ben-Dor D; Levartovsky S
Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
[No Abstract] [Full Text] [Related]
15. Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.
Sammarco MG; Pagliara MM; Savino G; Giannuzzi F; Carlà MM; Caputo CG; Blasi MA
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4305-4314. PubMed ID: 36074189
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
[TBL] [Abstract][Full Text] [Related]
18. Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
Panda A; Bajaj MS; Balasubramanya R; Prakash G
Am J Ophthalmol; 2003 Jan; 135(1):122-3; author reply 123-4. PubMed ID: 12504721
[No Abstract] [Full Text] [Related]
19. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
Hirst LW
Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
